Evidence map›Paper›PMID 40490460›Full record

ArticleBone marrow transplantation2025

Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.

Masahiro Teramoto, Yoshimitsu Shimomura, Hiroki Hosoi, Masamitsu Yanada, Shohei Mizuno, Naoyuki Uchida, Yasuo Mori, Noriko Doki, Wataru Takeda, Yuta Katayama and 12 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Masahiro TeramotoDepartment of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan. ma-teramoto@hyo-med.ac.jp.ORCID http://orcid.org/0000-0002-7569-6888
Yoshimitsu ShimomuraDepartment of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan.ORCID http://orcid.org/0000-0003-1018-9508
Hiroki HosoiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Masamitsu YanadaDepartment of Hematology and Oncology, Nagoya City University East Medical Center, Nagoya, Japan.ORCID http://orcid.org/0000-0003-1602-9775
Shohei MizunoDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.ORCID http://orcid.org/0000-0002-4405-8808
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-5952-5926
Yasuo MoriHematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.ORCID http://orcid.org/0000-0001-6425-1720
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8661-3179
Wataru TakedaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yuta KatayamaDepartment of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.ORCID http://orcid.org/0000-0001-5054-9104
Shuichi OtaDepartment of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.ORCID http://orcid.org/0000-0002-3631-244X
Hirohisa NakamaeDepartment of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-4203-990X
Takuro KuriyamaDepartment of Hematology, Hamanomachi Hospital, Fukuoka, Japan.ORCID http://orcid.org/0000-0001-7375-3183
Satoshi YoshiharaDepartment of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan.ORCID http://orcid.org/0000-0002-8537-2422
Masako ToyosakiDepartment of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Kazunori ImadaDepartment of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0002-0945-0513
Mamiko Sakata-YanagimotoDepartment of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.ORCID http://orcid.org/0000-0001-7310-8045
Makoto OnizukaDepartment of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.ORCID http://orcid.org/0000-0003-3864-0823
Junya KandaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6704-3633
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID http://orcid.org/0000-0003-4404-2870
Takaaki KonumaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1953-8463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40490460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.